Haya Therapeutics Completes Chf 18 Million Seed Financing To Advance Anti-Fibrotic Therapies Targeting Long Non-Coding Rnas
Round Type
Seed
LausanneBiotechnologyHealth CareScience And EngineeringDescription
HAYA Therapeutics, SA, a company developing precision medicines that target tissue and cell-specific long non-coding RNAs (lncRNAs), announced the successful closing of its CHF 18 million seed round. The financing was led by Broadview Ventures, with participation from Apollo Health Ventures, BERNINA BioInvest, 4See Ventures, Schroder Adveq and Viva BioInnovator.
Quick answer
Haya Therapeutics raised an undisclosed amount in a Seed round, dated May 20, 2021. Haya Therapeutics is based in Lausanne, Vaud, Switzerland.
- How much did Haya Therapeutics raise?
- Haya Therapeutics raised an undisclosed amount in a Seed round on May 20, 2021.
- What does Haya Therapeutics do?
- HAYA Therapeutics is a precision medicines company developing programmable therapeutics targeting regulatory RNAs derived from the dark genome, a cell information processing unit, to reprogram pathological cell states..
- Where is Haya Therapeutics based and how big is it?
- Haya Therapeutics is based in Lausanne, Vaud, Switzerland.
- Who are the decision-makers at Haya Therapeutics?
- Fundz holds 1 contact at Haya Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Haya Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- SeLux Diagnostics, Inc. raised $2.5M (Seed) on June 17, 2021.
- Camp4 Therapeutics Corp raised $45M (Funding Round) on June 15, 2021.
- MAIA Biotechnology raised $8M (Funding Round) on May 19, 2021.
- Triumvira Immunologics Inc. raised $16M on May 10, 2021.
- RetinalGeniX Technologies raised $45K (Pre-Seed) on July 1, 2021.
- Julier Medical raised an undisclosed amount on June 30, 2021.
Who to call at Haya Therapeutics, and when
A new round usually means Haya Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Haya Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Haya Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Haya Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Haya Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Haya Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.